Rifampicin-resistant TB: An inflection point in antimicrobial resistance
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Rifampicin-resistant TB should be integrated into the global AMR response through diagnostics, surveillance, and optimized treatment regimens.
Appeared: Friday, October 16. Science Translational Medicine. Peer-reviewed journal.